Skip to main content
. 2016 Jul 25;7:99. doi: 10.3389/fendo.2016.00099

Table 3.

Comparison between the 26 R0 patient in relationship to the adjuvant mitotane therapy.

Adjuvant mitotane No adjuvant therapy p
N 17 9
Age at diagnosis 45.1 ± 16.0 53.9 ± 19.9 0.2
Tumor size 9.4 ± 3.8 8.4 ± 4.0 0.5
Functioning tumors 10 3 0.4
Stage III–IV 7 1 0.2
Recurrence 8 4 0.9